Deep-tech company Chemify has raised more than $50m in an oversubscribed Series B funding round.
It was co-led by Wing Venture Capital and Insight Partners, with participation from a syndicate including 8VC and existing backers Triatomic Capital, Blueyard, Rockspring and Eos.
“Chemify aims to become the global digital backbone of chemistry, enabling fast design and discovery,” said Lee Cronin, founder and chief executive of the Glasgow University spin-out.
“Our vision is that Chemify will be able to design and make any molecule on demand for our customers across all of chemistry from drug discovery to new catalysts and electronic materials.
“The next step in our evolution is nothing short of a revolution in the digitisation and automation of chemical discovery and manufacturing.”
Earlier this year, Chemify launched its first Chemifarm, an automated chemistry facility built to be the most advanced laboratory for molecular design and synthesis.
Chemifarm integrates the Chemputation platform, a programming language, advanced robotics and the world’s largest curated library of validated reactions.
The new financing allows Chemify to expand this blueprint globally, building a network of digital chemistry hubs.
The company is planning a facility in Silicon Valley led by chief technical officer Mike Bell.
#Deeptech #spinout #Chemify #raises #million #Daily #Business